Development and in vivo evaluation of fused benzazole analogs of anti-melanoma agent HA15

Authors / Editors

Research Areas

No matching items found.

Publication Details

Output type: Journal article

UM6P affiliated Publication?: Yes

Author list: Millet, Antoine; Filho, Mauro Safir; Hamouda-Tekaya, Nedra; Cavazza, Elisa; Abbe, Patricia; Rudiger, Johanna; Plaisant, Magali; Mayen, Julie; Rocchi, Stephane; Ronco, Cyril; Benhida, Rachid

Publisher: Future Science: Newlands Press

Publication year: 2021

Journal: Future Medicinal Chemistry (1756-8919)

Volume number: 13

Issue number: 14

ISSN: 1756-8919

Languages: English (EN-GB)

View in Web of Science | View on publisher site | View citing articles in Web of Science


Background: In line with our recent discovery of an efficient anticancer thiazolebenzenesulfonamide framework HA15 (1) based on a remarkable endoplasmic reticulum stress inducement mode of action, we report herein a series of innovative constrained HA15 analogs, featuring four types of bicylic derivatives. Results: The structure-activity relationship analysis, using a cell line assay, led us to identify a novel version of HA15: a new benzothiazole derivative (10b) exhibiting important anti-melanoma effect against sensitive and resistant melanoma cells. Meanwhile, compound 10b induced a significant tumor growth inhibition in vivo with no apparent signs of toxicity. Conclusion: These results consistently open new directions to improve and develop more powerful anticancer therapeutics harboring this type of fused framework.


No matching items found.


No matching items found.

Last updated on 2021-20-09 at 23:22